Net Cash Provided by (Used in) Financing Activities of Ocugen, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ocugen, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Ocugen, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $1,245,000, a 759% decline year-over-year.
  • Ocugen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $17,328,000, a 73% decline from 2024.
  • Ocugen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $64,858,000, a 211% increase from 2023.
  • Ocugen, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $20,881,000, a 65% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Ocugen, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $17,328,000 -$47,530,000 -73% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $64,858,000 +$43,977,000 +211% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $20,881,000 -$38,594,000 -65% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $59,475,000 -$61,201,000 -51% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $120,676,000 +$89,065,000 +282% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $31,611,000 +$6,545,000 +26% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $25,066,000 +$17,881,453 +249% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $7,184,547 +$7,761,547 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $577,000 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY

Ocugen, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,245,000 -$1,100,000 -759% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $145,000 -$5,641,000 -103% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $5,496,000 -$44,606,000 -89% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $50,102,000 +$23,805,000 +91% 01 Jan 2022 31 Mar 2022 10-K 16 Apr 2024 2023 FY
Q1 2021 $26,297,000 +$25,809,000 +5289% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $488,000 -$870,803 -64% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $1,358,803 -$4,136,197 -75% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $5,495,000 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.